| 02/08 | Evaxion Biotech Says CEO Resigns, Per Norlen Named as Replacement; Shares Drop |  |
| 02/08 | EVAXION BIOTECH A/S: Announces Executive Management Changes - Form 6-K | |
| 02/08 | Evaxion Biotech A/S Announces Executive Management Changes | |
| 02/08 | Evaxion Biotech A/S Announces Executive Management Changes | |
| 02/08 | Evaxion Biotech A/S Announces Executive Management Changes | |
| 29/07 | Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10 | |
| 08/07 | BIOSTOCK: Evaxion Biotech expands its programme with a new indication | |
| 01/07 | Evaxion Biotech A/S Announces That It Is Ready for Recruitment for the Evx-01 Phase 2B .. | |
| 30/06 | Evaxion Biotech Announces Gonorrhea as Second Bacterial Product Target | |
| 30/06 | Evaxion Biotech Announces Gonorrhea as Second Bacterial Product Target | |
| 30/06 | Evaxion Biotech A/S Announces Gonorrhea as Second Bacterial Product Target | |
| 23/06 | Evaxion Biotech to Target Non-Small Cell Lung Cancer With Drug Candidate; Shares Rise P.. | |
| 23/06 | EVAXION BIOTECH A/S: Expands Its EVX-03 DNA Vaccine Program Into Non-Small Cell Lung Canc.. | |
| 23/06 | Evaxion Biotech Expands Its EVX-03 DNA Vaccine Program Into Non-Small Cell Lung Cancer | |
| 23/06 | Evaxion Biotech Expands Its EVX-03 DNA Vaccine Program Into Non-Small Cell Lung Cancer | |
| 23/06 | Evaxion Biotech Expands its EVX-03 DNA Vaccine Program into Non-Small Cell Lung Cancer | |
| 10/06 | BIOSTOCK: Evaxion Biotech Secures Equity Financing of up to 40 MUSD | |
| 07/06 | EVAXION BIOTECH A/S: Secures Equity Financing of up to $40 Million from Lincoln Park Capi.. | |
| 07/06 | Evaxion Biotech Says it has Secured Up To $40 Million in Equity Financing From Lincoln .. | |
| 07/06 | Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital | |
| 07/06 | Evaxion Biotech A/S announced that it expects to receive $40 million in funding from Li.. | |
| 19/05 | Evaxion Biotech A/S Approves Election of Niels Iversen Møller as New Member of the Boar.. | |
| 17/05 | European ADRs Move Higher in Tuesday Trading | |
| 16/05 | European ADRs Move Higher in Monday Trading | |
| 16/05 | BIOSTOCK: Evaxion Biotech shows strong clinical momentum in Q1 | |
| 12/05 | European ADRs Decline in Thursday Trading | |
| 11/05 | TRANSCRIPT: Evaxion Biotech A/S, Q1 2022 Earnings Call, May 11, 2022 | |
| 11/05 | Evaxion Biotech Announces First Quarter 2022 Financial Results and Provides Business Up.. | |
| 11/05 | Evaxion Biotech Announces First Quarter 2022 Financial Results and Provides Business Up.. | |
| 11/05 | Evaxion Biotech A/S Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 10/05 | SECTOR UPDATE: Health Care Stocks Still Edging Higher This Afternoon | |
| 10/05 | Wall Street Set for Recovery After Monday's Sell-Off | |
| 10/05 | Top Premarket Gainers | |
| 10/05 | Evaxion Biotech Announces Successful Production of Personalized Cancer Immunotherapies .. | |
| 10/05 | Evaxion Biotech Announces Successful Production of Personalized Cancer Immunotherapies .. | |
| 10/05 | Evaxion Biotech Announces Successful Production of Personalized Cancer Immunotherapies .. | |
| 10/05 | Evaxion Biotech Announces Successful Production of Personalized Cancer Immunotherapies .. | |
| 29/04 | Evaxion Biotech to Host Q1 2022 Corporate Update Conference Call & Webcast on May 11 | |
| 26/04 | Evaxion Biotech to Use Personalis Platform to Evaluate Efficacy of Skin Cancer Combinat.. | |
| 12/04 | EVAXION BIOTECH A/S: COMPLETE PROPOSALS - Form 6-K | |
| 12/04 | TRANSCRIPT: Evaxion Biotech A/S - Special Call | |
| 06/04 | Evaxion Biotech Hosting Key Opinion Leader Webinar on Metastatic Melanoma and Personali.. | |
| 05/04 | Evaxion Biotech A/S Announces Executive Changes | |
| 01/04 | EVAXION BIOTECH A/S: Annual Report by Foreign Issuer (Form 20-F) | |
| 22/03 | TRANSCRIPT: Evaxion Biotech A/S, Q4 2021 Earnings Call, Mar 22, 2022 | |
| 22/03 | EVAXION BIOTECH A/S: Announces Fourth Quarter and Full Year 2021 Financial Results and Pr.. | |
| 22/03 | Evaxion Biotech Announces Fourth Quarter and Full Year 2021 Financial Results and Provi.. | |
| 22/03 | Evaxion Biotech A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended.. | |
| 15/03 | EVAXION BIOTECH A/S: Strengthens Management Team with Two Senior Appointments - Form 6-K | |
| 15/03 | BIOSTOCK: Evaxion completes EVX-02 clinical trial recruitment | |
| 14/03 | Evaxion Biotech Appoints CFO, COO | |
| 14/03 | Evaxion Biotech Strengthens Management Team with Two Senior Appointments | |
| 14/03 | Evaxion Biotech A/S Appoints Bo Karmark as its Chief Financial Officer | |
| 14/03 | Evaxion Biotech A/S Appoints Jesper Nyegaard Nissen as its Chief Operating Officer | |
| 07/03 | EVAXION BIOTECH A/S: Completes Recruitment for Phase 1/2a Clinical Trial for EVX-02 - For.. | |
| 07/03 | Evaxion Biotech Completes Recruitment For Phase 1/2a Trial of EVX-02 in Adjuvant Melano.. | |
| 07/03 | Evaxion Biotech Completes Recruitment for Phase 1/2a Clinical Trial for EVX-02 | |
| 07/03 | Evaxion Biotech A/S Completes Recruitment for Phase 1/2a Clinical Trial for EVX-02 | |
| 09/02 | BIOSTOCK: Evaxion Biotech publishes EVX-01 data in scientific journal OncoImmunology | |
| 26/01 | Evaxion Biotech Announces Publication of Clinical Data of EVX-01 Heading into Phase 2b .. | |
| 26/01 | Evaxion Biotech Announces Publication of Clinical Data of EVX-01 Heading into Phase 2b .. | |
| 24/01 | BIOSTOCK: Evaxion Biotech gets a go-ahead for phase IIb with EVX-01 | |
| 18/01 | EVAXION BIOTECH A/S: Receives Regulatory Clearance to Initiate Phase 2 Trial of EVX-01 in.. | |
| 18/01 | Evaxion Biotech Receives Regulatory Clearance to Initiate Phase 2 Trial of EVX-01 in Co.. | |
| 18/01 | Evaxion Biotech Receives Regulatory Clearance to Initiate Phase 2 Trial of EVX-01 in Co.. | |
| 2021 | BIOSTOCK: Capital injection sets Evaxion Biotech up for phase IIb trials | |
| 2021 | EVAXION BIOTECH A/S INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEME.. | |
| 2021 | Evaxion Biotech Announces Closing of $27.6 Million Follow-on Public Offering, Including.. | |
| 2021 | Evaxion Biotech Announces Closing of $27.6 Million Follow-on Public Offering, Including.. | |
| 2021 | Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update - Form.. | |
| 2021 | Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update | |
| 2021 | Evaxion Biotech A/S Reports Earnings Results for the Third Quarter and Nine Months Ende.. | |
| 2021 | Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering - Form 6-K | |
| 2021 | Top Premarket Decliners | |
| 2021 | Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Espańol
Franēais (France)
Nederlands (Nederland)
Nederlands (Belgiė)
Rapporto
